Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria

This study determined the antimicrobial resistance profiles and molecularly characterized beta-lactam- and fluoroquinolone-resistant E. coli recovered from human clinical samples. Three hundred (300) clinical samples collected from two major tertiary healthcare institutions were analyzed using stand...

Full description

Bibliographic Details
Main Authors: E. Egwu, F.A. Ibiam, I.B. Moses, C.S. Iroha, I. Orji, F.N. Okafor-Alu, C.O. Eze, I.R. Iroha
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Scientific African
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468227623003186
_version_ 1797676206880980992
author E. Egwu
F.A. Ibiam
I.B. Moses
C.S. Iroha
I. Orji
F.N. Okafor-Alu
C.O. Eze
I.R. Iroha
author_facet E. Egwu
F.A. Ibiam
I.B. Moses
C.S. Iroha
I. Orji
F.N. Okafor-Alu
C.O. Eze
I.R. Iroha
author_sort E. Egwu
collection DOAJ
description This study determined the antimicrobial resistance profiles and molecularly characterized beta-lactam- and fluoroquinolone-resistant E. coli recovered from human clinical samples. Three hundred (300) clinical samples collected from two major tertiary healthcare institutions were analyzed using standard microbiological techniques. Antimicrobial susceptibility testing and phenotypic detection of extended-spectrum beta-lactamase (ESBL) were done by disc diffusion and Double Disk Synergy Test. Molecular characterization for ESBL and fluoroquinolone-resistant genes were done by PCR with specific primers. In total, 44 (14.7%) ESBL-producing E. coli were recovered from human clinical specimens. The recovered isolates were multidrug-resistant with multiple antibiotics resistance index values ranging from 0.5–0.8. Isolates exhibited resistance to sulfamethoxazole/trimethoprim 44 (100%), cefoxitin 42 (95.5%), tetracycline 42 (95.5 %), cefuroxime 41 (93.2%), ciprofloxacin 40 (90.9%), cefotaxime 37 (84.1%), amoxicillin 37 (84.1%), amoxicillin/clavulanic acid 37 (84.1), and ceftazidime 35 (79.5%). BlaTEM 41 (93.2%) ESBL gene was the most predominant gene among the isolates, followed by blaCTX-M 9 (20.5%), and blaSHV 1 (2.3%) genes. Co-existence of blaTEM +blaSHV, blaTEM + blaCTX-M, and blaTEM +blaSHV + blaCTX-M genes was observed in 1 (2.3%), 7 (15.9%), and 4 (9.1%) isolates, respectively. All the fluoroquinolone-resistant isolates harbored aac-lb-6-cr gene while Qnr gene was absent. Association of fluoroquinolone resistance- and β-lactam resistance genes; aac-lb-6-cr + blaTEM + blaSHV + blaCTM was observed in 5 (11.4%) isolates. Our study showed high frequency of ESBL-producing E. coli harboring ESBL and fluoroquinolone resistance genes from human clinical samples in Ebonyi State, Nigeria. The high frequency of multidrug-resistant E. coli in our study is very worrisome and could have significant public health impact such as treatment failures, and possibly death, if not properly managed. It is therefore imperative to establish strong regulative measures and guidelines that would help in curtailing the increasing dissemination of these superbugs in healthcare institutions in Nigeria.
first_indexed 2024-03-11T22:25:39Z
format Article
id doaj.art-351616222fc2455ea59ddf55189bbf18
institution Directory Open Access Journal
issn 2468-2276
language English
last_indexed 2024-03-11T22:25:39Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Scientific African
spelling doaj.art-351616222fc2455ea59ddf55189bbf182023-09-24T05:16:25ZengElsevierScientific African2468-22762023-09-0121e01863Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in NigeriaE. Egwu0F.A. Ibiam1I.B. Moses2C.S. Iroha3I. Orji4F.N. Okafor-Alu5C.O. Eze6I.R. Iroha7Medical Laboratory Unit, Laboratory Service Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, NigeriaOtorhinLaryngology Department (ENT), Alex Ekwueme Federal University Ndufu-Alike Ikwo, NigeriaDepartment of Applied Microbiology, Faculty of Sciences, Ebonyi State University, P.M.B. 053, Abakaliki, Nigeria; Corresponding author.Pharmacy Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, NigeriaMedical Laboratory Unit, Laboratory Service Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, NigeriaMedical Laboratory Unit, Laboratory Service Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, NigeriaInternal Medicine Department, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, NigeriaDepartment of Applied Microbiology, Faculty of Sciences, Ebonyi State University, P.M.B. 053, Abakaliki, NigeriaThis study determined the antimicrobial resistance profiles and molecularly characterized beta-lactam- and fluoroquinolone-resistant E. coli recovered from human clinical samples. Three hundred (300) clinical samples collected from two major tertiary healthcare institutions were analyzed using standard microbiological techniques. Antimicrobial susceptibility testing and phenotypic detection of extended-spectrum beta-lactamase (ESBL) were done by disc diffusion and Double Disk Synergy Test. Molecular characterization for ESBL and fluoroquinolone-resistant genes were done by PCR with specific primers. In total, 44 (14.7%) ESBL-producing E. coli were recovered from human clinical specimens. The recovered isolates were multidrug-resistant with multiple antibiotics resistance index values ranging from 0.5–0.8. Isolates exhibited resistance to sulfamethoxazole/trimethoprim 44 (100%), cefoxitin 42 (95.5%), tetracycline 42 (95.5 %), cefuroxime 41 (93.2%), ciprofloxacin 40 (90.9%), cefotaxime 37 (84.1%), amoxicillin 37 (84.1%), amoxicillin/clavulanic acid 37 (84.1), and ceftazidime 35 (79.5%). BlaTEM 41 (93.2%) ESBL gene was the most predominant gene among the isolates, followed by blaCTX-M 9 (20.5%), and blaSHV 1 (2.3%) genes. Co-existence of blaTEM +blaSHV, blaTEM + blaCTX-M, and blaTEM +blaSHV + blaCTX-M genes was observed in 1 (2.3%), 7 (15.9%), and 4 (9.1%) isolates, respectively. All the fluoroquinolone-resistant isolates harbored aac-lb-6-cr gene while Qnr gene was absent. Association of fluoroquinolone resistance- and β-lactam resistance genes; aac-lb-6-cr + blaTEM + blaSHV + blaCTM was observed in 5 (11.4%) isolates. Our study showed high frequency of ESBL-producing E. coli harboring ESBL and fluoroquinolone resistance genes from human clinical samples in Ebonyi State, Nigeria. The high frequency of multidrug-resistant E. coli in our study is very worrisome and could have significant public health impact such as treatment failures, and possibly death, if not properly managed. It is therefore imperative to establish strong regulative measures and guidelines that would help in curtailing the increasing dissemination of these superbugs in healthcare institutions in Nigeria.http://www.sciencedirect.com/science/article/pii/S2468227623003186E. coliMultidrug resistanceESBL genesFluoroquinolone-resistant genesHuman clinical samples
spellingShingle E. Egwu
F.A. Ibiam
I.B. Moses
C.S. Iroha
I. Orji
F.N. Okafor-Alu
C.O. Eze
I.R. Iroha
Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
Scientific African
E. coli
Multidrug resistance
ESBL genes
Fluoroquinolone-resistant genes
Human clinical samples
title Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
title_full Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
title_fullStr Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
title_full_unstemmed Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
title_short Antimicrobial susceptibility and molecular characteristics of beta-lactam- and fluoroquinolone-resistant E. coli from human clinical samples in Nigeria
title_sort antimicrobial susceptibility and molecular characteristics of beta lactam and fluoroquinolone resistant e coli from human clinical samples in nigeria
topic E. coli
Multidrug resistance
ESBL genes
Fluoroquinolone-resistant genes
Human clinical samples
url http://www.sciencedirect.com/science/article/pii/S2468227623003186
work_keys_str_mv AT eegwu antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT faibiam antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT ibmoses antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT csiroha antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT iorji antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT fnokaforalu antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT coeze antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria
AT iriroha antimicrobialsusceptibilityandmolecularcharacteristicsofbetalactamandfluoroquinoloneresistantecolifromhumanclinicalsamplesinnigeria